IQVIA Holdings Balance Sheet Health

Financial Health criteria checks 1/6

IQVIA Holdings has a total shareholder equity of $6.1B and total debt of $13.7B, which brings its debt-to-equity ratio to 224.5%. Its total assets and total liabilities are $26.7B and $20.6B respectively. IQVIA Holdings's EBIT is $2.1B making its interest coverage ratio 3.3. It has cash and short-term investments of $1.5B.

Key information

224.5%

Debt to equity ratio

US$13.72b

Debt

Interest coverage ratio3.3x
CashUS$1.50b
EquityUS$6.11b
Total liabilitiesUS$20.57b
Total assetsUS$26.68b

Recent financial health updates

Recent updates

Is IQVIA Holdings (NYSE:IQV) Using Too Much Debt?

Apr 11
Is IQVIA Holdings (NYSE:IQV) Using Too Much Debt?

IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Not Quite Adding Up

Mar 27
IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Not Quite Adding Up

Here's Why IQVIA Holdings (NYSE:IQV) Has Caught The Eye Of Investors

Mar 14
Here's Why IQVIA Holdings (NYSE:IQV) Has Caught The Eye Of Investors

IQVIA Holdings: Strong Q4 Results Suggest A Bullish 2024

Feb 22

Is IQVIA Holdings Inc. (NYSE:IQV) Trading At A 29% Discount?

Jan 23
Is IQVIA Holdings Inc. (NYSE:IQV) Trading At A 29% Discount?

Market Participants Recognise IQVIA Holdings Inc.'s (NYSE:IQV) Earnings

Dec 24
Market Participants Recognise IQVIA Holdings Inc.'s (NYSE:IQV) Earnings

We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

Dec 08
We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

Should You Investigate IQVIA Holdings Inc. (NYSE:IQV) At US$205?

Nov 23
Should You Investigate IQVIA Holdings Inc. (NYSE:IQV) At US$205?

IQVIA Q3: TAS Segment Remains The Problem Child

Nov 21

IQVIA: I Would Stay Away Until Debt Issues Are Resolved

Nov 12

Is There An Opportunity With IQVIA Holdings Inc.'s (NYSE:IQV) 32% Undervaluation?

Oct 08
Is There An Opportunity With IQVIA Holdings Inc.'s (NYSE:IQV) 32% Undervaluation?

IQVIA: Stock To Remain Rangebound As I Expect Weak Numbers In The Near Term

Sep 07

Is IQVIA Holdings (NYSE:IQV) A Risky Investment?

Sep 04
Is IQVIA Holdings (NYSE:IQV) A Risky Investment?

Why IQVIA Holdings Inc. (NYSE:IQV) Could Be Worth Watching

Aug 11
Why IQVIA Holdings Inc. (NYSE:IQV) Could Be Worth Watching

IQVIA Holdings Q2: Breaking Ground And Beating Expectations

Aug 03

IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 43% Above Its Share Price

Jun 27
IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 43% Above Its Share Price

IQVIA Holdings (NYSE:IQV) Has A Pretty Healthy Balance Sheet

Jun 05
IQVIA Holdings (NYSE:IQV) Has A Pretty Healthy Balance Sheet

IQVIA Holdings: A Possible Beat And Raise Scenario In The Works

May 23

What Does IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Indicate?

May 04
What Does IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Indicate?

A Look At The Fair Value Of IQVIA Holdings Inc. (NYSE:IQV)

Mar 19
A Look At The Fair Value Of IQVIA Holdings Inc. (NYSE:IQV)

Does IQVIA Holdings (NYSE:IQV) Have A Healthy Balance Sheet?

Mar 05
Does IQVIA Holdings (NYSE:IQV) Have A Healthy Balance Sheet?

Here's Why We Think IQVIA Holdings (NYSE:IQV) Might Deserve Your Attention Today

Feb 12
Here's Why We Think IQVIA Holdings (NYSE:IQV) Might Deserve Your Attention Today

IQVIA Q4 2022 Earnings Preview

Feb 09

When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

Jan 29
When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

IQVIA Holdings: Premium Valuation Is Justified For An Industry Leader

Jan 24

We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

Nov 09
We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

IQVIA Holdings Sees Digital Opportunities, But Debt Drags Growth

Nov 02

IQVIA Q3 2022 Earnings Preview

Oct 25

Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?

Oct 02
Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?

IQVIA: Rebound Is Likely But Downtrend Is Still Intact (Technical Analysis)

Sep 19

With EPS Growth And More, IQVIA Holdings (NYSE:IQV) Makes An Interesting Case

Aug 22
With EPS Growth And More, IQVIA Holdings (NYSE:IQV) Makes An Interesting Case

GSK, Iqvia launch Vaccine Track platform to highlight vaccine trends publicly in US

Aug 11

We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

Aug 08
We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

IQVIA: Resiliency And Quality Never Left, Q2 Earnings Evidence The Same

Jul 28

Are Investors Undervaluing IQVIA Holdings Inc. (NYSE:IQV) By 48%?

Jul 26
Are Investors Undervaluing IQVIA Holdings Inc. (NYSE:IQV) By 48%?

IQVIA Non-GAAP EPS of $2.44 beats by $0.06, revenue of $3.54B beats by $50M, raises FY22 guidance

Jul 21

IQVIA A Smart Choice In A High-Inflation Environment

Apr 29

When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

Mar 28
When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

Here's Why We Think IQVIA Holdings (NYSE:IQV) Is Well Worth Watching

Mar 01
Here's Why We Think IQVIA Holdings (NYSE:IQV) Is Well Worth Watching

IQVIA: Intelligent Healthcare Solutions For A Growing Market

Feb 19

IQVIA Holdings (NYSE:IQV) Seems To Use Debt Quite Sensibly

Feb 17
IQVIA Holdings (NYSE:IQV) Seems To Use Debt Quite Sensibly

Is Now An Opportune Moment To Examine IQVIA Holdings Inc. (NYSE:IQV)?

Dec 16
Is Now An Opportune Moment To Examine IQVIA Holdings Inc. (NYSE:IQV)?

Is There An Opportunity With IQVIA Holdings Inc.'s (NYSE:IQV) 33% Undervaluation?

Dec 01
Is There An Opportunity With IQVIA Holdings Inc.'s (NYSE:IQV) 33% Undervaluation?

Financial Position Analysis

Short Term Liabilities: IQV's short term assets ($5.6B) do not cover its short term liabilities ($6.5B).

Long Term Liabilities: IQV's short term assets ($5.6B) do not cover its long term liabilities ($14.1B).


Debt to Equity History and Analysis

Debt Level: IQV's net debt to equity ratio (200.1%) is considered high.

Reducing Debt: IQV's debt to equity ratio has increased from 158.5% to 224.5% over the past 5 years.

Debt Coverage: IQV's debt is not well covered by operating cash flow (15.7%).

Interest Coverage: IQV's interest payments on its debt are well covered by EBIT (3.3x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.